GLP-1 for Diabetes & Weight Loss: Results, Cost & Side Effects

Clinical trials have shown average weight reductions of 10% or more in some treatment groups, but those figures are not guarantees for an individual patient. People with type 2 diabetes may also lose less weight than people with obesity who do not have diabetes. Nausea, vomiting, diarrhoea, constipation and abdominal discomfort are among the most common side effects. For many patients, the bigger question is what happens over the long term. Weight can return after treatment is stopped, which is why GLP-1 therapy needs to be considered as part of an ongoing medical plan rather than a short-term injection course.

GLP-1 medicines have become an important part of treatment for many people with type 2 diabetes and obesity. They can lower blood glucose, reduce appetite and help some patients achieve substantial weight loss.

That does not mean the experience is the same for everyone.

One person may lose a significant amount of weight and tolerate the medicine well. Another may see a smaller change, experience troublesome nausea or find the ongoing cost difficult to manage. The medicine itself is only one part of the picture.

There is also a difference between what clinical trials show and what people see on social media. Online posts often focus on dramatic transformations without explaining the starting weight, treatment duration, dose, lifestyle changes or side effects involved.

For someone considering GLP-1 treatment in Muscat or elsewhere in Oman, a more useful question is not simply, "How much weight will I lose?" It is whether the expected benefit, possible risks, cost and long-term treatment plan make sense for that individual.

What Are GLP-1 Medicines?

GLP-1 stands for glucagon-like peptide-1. It is a hormone produced naturally in the digestive system.

After food is eaten, GLP-1 helps coordinate several processes involved in controlling blood glucose and appetite. Medicines that act on this pathway extend or strengthen some of these effects.

Depending on the medicine, GLP-1-based treatment can:

• Increase insulin release when blood glucose is elevated

• Reduce glucagon release

• Slow the movement of food through the stomach

• Increase feelings of fullness

• Reduce appetite

• Improve blood glucose control

• Support weight loss

Not all medicines in this group are identical. Their approved uses, dosing schedules, side effects and precautions differ.

Tirzepatide is an important example. It works through both the GIP and GLP-1 pathways, rather than through GLP-1 alone.

How Do GLP-1 Medicines Help With Diabetes?

For people with type 2 diabetes, GLP-1-based medicines can improve blood glucose while also helping with weight management.

One part of their effect comes from increasing insulin secretion when blood glucose is elevated. They also reduce glucagon activity, which can lower the amount of glucose released by the liver.

Their effects on appetite and stomach emptying can further influence food intake and blood glucose after meals.

GLP-1 medicines are not a replacement for insulin in someone who needs insulin treatment.

Choosing a diabetes medicine involves more than looking at the HbA1c result. Doctors may also consider body weight, cardiovascular disease, kidney function, other medications, risk of hypoglycemia, side effects, cost and the patient's treatment goals.

For someone with type 2 diabetes who also has overweight or obesity, a medicine that addresses both glucose control and weight may be particularly useful when it is clinically appropriate.

How Much Weight Can You Really Lose With GLP-1 Medicines?

There is no single number that represents a "normal" GLP-1 weight-loss result.

Clinical trials are useful because they show what happened to groups of patients under defined conditions. They cannot predict exactly what will happen to one individual.

For example, participants in the STEP 1 trial who had overweight or obesity without diabetes and received semaglutide 2.4 mg alongside lifestyle intervention lost an average of about 14.9% of their starting body weight after 68 weeks. The placebo group lost about 2.4%.

Tirzepatide has also produced substantial weight loss in clinical trials. In SURMOUNT-1, adults with obesity or overweight and weight-related health problems lost an average of roughly 15% to 21% of their starting weight after 72 weeks, depending on the dose studied.

Those numbers help establish what the medicines can do under trial conditions. They should not be read as a promise that every patient will lose 15% or 20% of their body weight.

Why Does Weight Loss Differ From Person to Person?

Several things can influence the response.

These include:

• Starting body weight

• Whether the person has type 2 diabetes

• The medicine being used

• Treatment dose

• Duration of treatment

• Ability to tolerate dose increases

• Eating pattern

• Physical activity

• Other medications

• Other medical conditions

• Adherence to treatment

There is also considerable individual variation in how the body responds to medication.

People with type 2 diabetes sometimes lose less weight than people without diabetes who have a similar starting weight. That does not necessarily mean the medicine is not helping.

For a person with diabetes, improved HbA1c, better glucose control and lower metabolic risk may be important outcomes even if weight loss is more modest than expected.

What Does Realistic GLP-1 Weight Loss Look Like?

GLP-1 treatment is not designed to produce an overnight transformation.

Treatment is generally started at a lower dose and increased gradually according to the specific medicine and the patient's tolerance. Weight loss can begin during the early stages, but the larger effects seen in clinical trials developed over many months.

This is where social media can be misleading.

A post showing a dramatic transformation rarely tells you the full story. You may not know:

• The person's starting weight

• Their treatment duration

• Which medicine they used

• The dose they reached

• Whether they had diabetes

• What changes they made to their diet

• How active they were

• Whether they experienced side effects

• Whether they continued treatment afterward

A clinical trial provides a much more useful reference point than an individual transformation posted online.

Do GLP-1 Medicines Work Without Diet and Exercise?

GLP-1 treatment does not make healthy eating and physical activity irrelevant.

In clinical practice, medication is usually one component of a broader weight-management strategy.

The appetite-suppressing effect can make it easier for some people to reduce food intake. But nutrition, movement, sleep and other aspects of metabolic health still matter.

There is also more to successful obesity treatment than the number on the weighing scale.

A medical weight-management plan may consider blood pressure, diabetes, cholesterol, fatty liver disease, sleep apnea, cardiovascular risk, mobility and overall quality of life.

What Are the Common Side Effects of GLP-1 Medicines?

Most of the commonly reported side effects involve the digestive system.

Patients may experience:

• Nausea

• Vomiting

• Diarrhoea

• Constipation

• Bloating

• Abdominal discomfort

• Indigestion

• Reduced appetite

These symptoms are often more noticeable when treatment is first started or when the dose is increased.

Some people find that the symptoms settle as their body adjusts. Others continue to have problems and may need their treatment reviewed.

A side effect should not automatically be dismissed as something that must simply be tolerated.

Why Do GLP-1 Medicines Cause Nausea?

GLP-1-based medicines influence appetite and the rate at which food moves through the stomach.

That is part of why they can help people feel full after eating less. The same effect can also leave some people feeling uncomfortably full or nauseated.

Large meals, eating quickly and foods that are particularly rich or fatty may make symptoms worse for some people.

This is one reason the gradual introduction of treatment matters.

What Can Help With Mild Nausea?

Simple measures may make mild symptoms easier to manage:

• Eat smaller meals.

• Take your time while eating.

• Stop eating when you feel comfortably full.

• Choose simpler foods when nausea is troublesome.

• Drink enough fluid.

• Pay attention to foods that consistently make symptoms worse.

These measures are not a substitute for medical assessment. If nausea or vomiting is persistent, severe or associated with dehydration, contact a healthcare professional.

Can GLP-1 Medicines Cause Serious Side Effects?

They can, although serious complications are much less common than the everyday gastrointestinal effects.

Potential complications include gallbladder disease, pancreatitis and significant gastrointestinal problems.

There are also important warnings for some medicines in this class concerning thyroid C-cell tumours. These warnings are based on findings in rodents, and the relevance to humans has not been established. Nevertheless, certain GLP-1-based medicines should not be used in people with a personal or family history of medullary thyroid carcinoma or in people with Multiple Endocrine Neoplasia syndrome type 2.

People with diabetes who have existing diabetic retinopathy may also require particular attention when treatment is started.

There have also been safety concerns involving vision. Oman's Ministry of Health Drug Safety Center issued a 2026 safety communication regarding a reported risk of non-arteritic anterior ischemic optic neuropathy associated with semaglutide products.

That warning does not mean that vision problems are expected in everyone taking semaglutide. Sudden or significant visual changes should, however, be assessed promptly.

When Should You Seek Urgent Medical Attention?

Do not assume that every new symptom after starting a GLP-1 medicine is simply a normal side effect.

Urgent medical assessment may be necessary if you develop:

• Severe or persistent abdominal pain

• Repeated vomiting and inability to keep fluids down

• Significant dehydration

• Severe weakness or fainting

• Symptoms of a severe allergic reaction

• Sudden changes in vision

• Severe hypoglycemia

• Confusion or loss of consciousness

• Other symptoms that feel sudden or serious

Severe abdominal pain, particularly when it persists or occurs with vomiting, deserves medical assessment rather than self-treatment.

Can GLP-1 Medicines Cause Low Blood Sugar?

GLP-1 medicines generally have a relatively low risk of hypoglycemia when used alone because their insulin-stimulating effect is linked to elevated glucose levels.

The situation changes when they are combined with insulin or certain other diabetes medicines, particularly sulfonylureas.

This is one reason the rest of a person's diabetes treatment may need to be reviewed when a GLP-1 medicine is introduced.

Do not independently reduce, stop or increase another diabetes medicine. Changes should be made with appropriate medical guidance.

How Much Do GLP-1 Medicines Cost?

There is no single GLP-1 price that applies to every patient.

The amount paid can depend on:

• The specific medicine

• Strength and dose

• Brand and formulation

• Pharmacy

• Country

• Insurance coverage

• Employer or health-plan benefits

• Treatment duration

• Local availability

For patients in Oman, current local prices and availability should be checked before making a decision.

International websites and social-media posts can quickly become outdated. A price quoted for a particular country may also have little relevance to what a patient pays in Muscat.

For that reason, fixed monthly prices should not be treated as universal.

Why Were GLP-1 Medicines So Expensive and Difficult to Access?

Demand for GLP-1-based medicines increased sharply as their role in diabetes and obesity treatment became more widely recognised.

Supply has had to catch up with that demand. Manufacturing capacity, regulatory approval, distribution, pharmacy availability and insurance coverage all affect access.

The market has also changed as additional products and manufacturers have entered the field.

But "more available globally" does not necessarily mean "cheap everywhere."

The price and availability of a particular medicine in Oman can differ from the situation in the United States, Europe or another market.

For patients, the practical question is therefore not whether GLP-1 medicines are becoming cheaper in general. It is what an appropriate, approved treatment will actually cost them locally and whether that cost can be sustained.

Are Cheaper or Compounded GLP-1 Medicines Safe?

Lower-cost versions advertised online can be tempting, particularly when branded medicines are expensive.

Price alone, however, does not tell you whether a product is appropriate.

Regulatory authorities have raised concerns about some compounded GLP-1 products, including dosing errors, differences in concentration and quality-control issues. The FDA has reported adverse events associated with dosing errors involving compounded semaglutide, including cases serious enough to require hospital treatment.

There have also been warnings about falsified GLP-1 products.

Patients should therefore be cautious about medicines purchased from unverified websites, social-media sellers or informal sources.

Prescription medicines should come through legitimate medical and pharmacy channels. The product, formulation and source should be clear.

Is a GLP-1 Medicine Worth the Cost?

That depends on the individual.

A useful discussion with a doctor goes beyond asking whether the medicine produces weight loss. It should consider what health problems the treatment is expected to improve and whether the expected benefit justifies the financial and practical burden.

Factors may include:

• Blood glucose control

• HbA1c

• Body weight

• Obesity-related complications

• Cardiovascular risk

• Kidney health

• Previous treatment

• Expected response

• Side effects

• Other medications

• Long-term affordability

• Personal treatment goals

For some patients, meaningful improvement in diabetes control and weight-related health risks may make treatment worthwhile.

For others, the cost, side effects or lack of response may lead to a different treatment strategy.

There is no universal answer.

How Long Do You Need to Take a GLP-1 Medicine?

The answer depends partly on why the medicine was prescribed.

For type 2 diabetes, medication may form part of long-term glucose management.

For obesity, weight-management medicines are increasingly considered longer-term treatments when they are effective and tolerated. Obesity is a chronic condition, and stopping an effective medicine can allow appetite and weight to return.

This has been demonstrated in clinical studies.

In the follow-up to the STEP 1 trial, participants who stopped semaglutide regained a substantial amount of the weight they had previously lost.

A similar pattern was seen in SURMOUNT-4 with tirzepatide. Participants who switched from tirzepatide to placebo regained a significant amount of weight, whereas continued treatment was associated with further weight reduction.

This does not mean that every patient must take a GLP-1 medicine permanently.

It does mean that the possibility of weight regain should be part of the conversation before treatment starts.

What Happens When You Stop a GLP-1 Medicine?

Weight regain is possible after stopping treatment.

The reason is straightforward: the biological factors that contributed to excess weight do not necessarily disappear simply because a person has lost weight. Appetite can increase again, and the medication's effects on food intake are no longer present.

How much weight returns varies from person to person.

The clinical studies of semaglutide and tirzepatide provide an important lesson: stopping treatment can result in significant weight regain for many patients.

Anyone considering stopping a GLP-1 medicine should discuss the plan with their doctor. Blood glucose, appetite, weight and other relevant health measures may need to be followed afterward.

Who May Be Considered for GLP-1 Treatment?

GLP-1-based treatment may be appropriate for selected people with type 2 diabetes and for eligible people with overweight or obesity, depending on the medicine and its approved indications.

A doctor may consider it when:

• Blood glucose remains above the desired range despite appropriate treatment

• Excess weight is contributing to metabolic health problems

• Obesity is associated with complications such as diabetes or cardiovascular risk

• A medicine with weight-management benefits fits the person's treatment goals

• There are no important contraindications

• The patient can safely tolerate treatment

• The expected benefits justify the cost and practical demands

Not everyone who wants to lose a few kilograms needs prescription medication.

Treatment decisions should be based on health needs rather than the popularity of injections online.

Who May Need Extra Caution With GLP-1 Medicines?

Some medical histories require additional consideration before treatment begins.

These may include:

• Previous pancreatitis

• Severe gastrointestinal disease

• Severe gastroparesis

• Gallbladder problems

• Diabetic retinopathy

• Certain thyroid cancer histories

• Multiple Endocrine Neoplasia syndrome type 2

• Use of medicines that increase hypoglycemia risk

• Conditions that could make dehydration particularly dangerous

Pregnancy also needs special consideration. Weight-loss treatment with GLP-1 medicines is not appropriate during pregnancy, and anyone planning pregnancy should discuss treatment with their doctor.

The exact precautions depend on the particular medicine. A medication that is suitable for one patient may not be suitable for another.

What Should You Ask Before Starting a GLP-1 Medicine?

A good consultation should cover more than the name of the injection.

Useful questions include:

1. Is this medicine appropriate for my diabetes or weight-management goals?

2. What would be a realistic treatment response for me?

3. How will we know whether the medicine is working?

4. How long might I need to continue treatment?

5. Which side effects should I expect?

6. Which symptoms should prompt me to seek medical help?

7. Could it interact with my current diabetes medicines?

8. Do any of my existing medical conditions make it unsuitable?

9. How will my blood glucose, weight and other health measures be monitored?

10. What happens if I do not respond well?

11. What would treatment cost over the longer term?

12. What is the plan if I eventually need to stop?

Those questions can lead to a much more useful treatment discussion than simply asking which medicine produces the fastest weight loss.

GLP-1 Treatment in Muscat: What Should Patients Consider?

Patients researching GLP-1 treatment in Muscat are likely to encounter a mixture of medical information, personal testimonials and commercial advertising.

It helps to separate three different questions.

Does the treatment have good evidence behind it?

Yes. Several GLP-1-based medicines, as well as the dual GIP/GLP-1 medicine tirzepatide, have substantial clinical evidence supporting their use in appropriate patients with type 2 diabetes and/or obesity, depending on the product and indication.

Will it work for me?

That cannot be answered from an online article. Individual response varies, and diabetes, other medical conditions, current medications and treatment tolerance all matter.

Can I afford to stay on it?

That requires current local information. Pharmacy prices, availability and insurance coverage can change, so these should be checked before treatment is started.

For someone considering treatment, an Internal Medicine consultation can put the medication into the wider context of diabetes, obesity, cardiovascular risk and overall metabolic health.

Myth vs Fact

Myth: Everyone taking a GLP-1 medicine loses the same amount of weight.

Fact

Clinical trials report averages across groups of patients. Individual results vary. Some people lose substantial amounts of weight, while others have a smaller response or stop treatment because of side effects.

Myth: GLP-1 medicines mean you no longer need to change your lifestyle.

Fact

Medication can make appetite and weight management easier for some people, but nutrition, physical activity, sleep and other lifestyle factors remain important. Medication and lifestyle treatment are not competing approaches.

Myth: Losing more weight always means better treatment.

Fact

Weight is only one measure of treatment response. Blood glucose, HbA1c, blood pressure, cardiovascular risk, kidney health, physical function and treatment tolerability also matter.

Myth: Once you stop a GLP-1 medicine, the weight stays off.

Fact

Weight regain is common after discontinuation. Studies involving semaglutide and tirzepatide have shown substantial regain in many participants after treatment was withdrawn.

Myth: The cheapest GLP-1 product is automatically the best choice.

Fact

Price is only one consideration. A treatment also needs to be appropriately indicated, properly supplied, medically suitable and tolerable. A cheaper product obtained from an unreliable source can carry additional risks.

You may also find these guides helpful: Why Is It So Hard to Lose Weight? Medical and Lifestyle Factors That Can Affect Weight, Lifestyle Changes vs Weight-Loss Medication: Which Approach Is Right for Obesity?, Are Weight-Loss Injections Safe? Benefits, Risks and What Patients Should Know.

Final Thoughts

Which guides go deeper on this topic?

• GLP-1 Medicines: Why They Are Becoming More Accessible

• How Much Weight Can You Lose on GLP-1 Medicines?

• GLP-1 Side Effects and How to Manage Them

• Is a GLP-1 Medicine Worth the Cost?

• What Happens When You Stop a GLP-1 Medicine?

GLP-1 medicines have changed what is possible in the treatment of type 2 diabetes and obesity. They can produce substantial improvements for some patients, but they are not a universal solution and they are not risk-free.

The most useful way to judge treatment is to look at the whole picture: blood glucose, weight, other medical conditions, side effects, lifestyle, cost and what happens over time.

Affordability deserves particular attention. A medicine that works but cannot realistically be continued may not be a sustainable treatment plan.

If you are considering a GLP-1 medicine, discuss your medical history, current medications, expected benefits, possible side effects and long-term cost with a qualified doctor before starting treatment.